Duolac is a premium probiotics brand from South Korea, owned and developed by Cell Biotech Co., Ltd., a biotechnology company established in 1995. The brand focuses on live bacterial supplements designed for digestive and microbiome health. Duolac is distinguished by its proprietary dual-coating technology, which aims to enhance the survival rate of probiotic bacteria through the gastrointestinal tract.

The name “Duolac” derives from the concepts of “Dual Coated” and “Lactic Acid Bacteria.” 1

Cell Biotech was founded in 1995 in South Korea as a specialist biotechnology company focusing on lactic-acid bacteria and probiotics. Early in its history, the company established production and research capabilities, subsequently expanding into large-scale probiotic manufacturing. 2

A significant milestone occurred with the development of dual-coated lactic acid bacteria technology. Patents related to this technology were registered in Korea and Japan in 2004, followed by a European patent in 2008.

According to the company’s international brand history, the Duolac brand was launched in 2010. Since then, it has expanded from a domestic Korean brand to an international presence, entering markets such as Denmark, Singapore, France, and Poland.

Note: Corporate materials in Korea describe an earlier introduction of the brand in 2005, while the international site cites the 2010 launch for the modern Duolac brand story.

Dual-Coating Technology

The core differentiator for Duolac is its dual-coating system. Probiotic bacteria are living microorganisms susceptible to environmental factors like moisture, stomach acid, and bile. Duolac surrounds its probiotic material with a protective coating intended to improve stability and survival during passage through the gut. The company claims this patented technology results in a 100-times higher survival rate in the intestine compared to uncoated strains under their testing methodology. This is a manufacturer claim rather than a universally accepted clinical conclusion. 1

Strain Sourcing and Research

Duolac states that its probiotic strains are isolated from sources including healthy humans, breastfed infants, and traditional Korean fermented foods. Rather than using generic bacterial mixes, the company emphasizes specific strain identification, characteristics, and formulation. Cell Biotech operates a dedicated research organization covering strain management, microbiome research, and clinical applications. The brand references 83 published papers regarding the safety and efficacy of its strains.

One-Stop Manufacturing

Cell Biotech maintains vertical integration over much of its production process, described as a “one-stop solution.” This internal control covers:

• Strain isolation and research
• Strain development
• Fermentation
• Dual coating
• Freeze-drying
• Strain blending
• Product manufacturing
• Quality inspection
• Distribution

Duolac products are exported internationally, with dedicated operations in markets including Korea, Singapore, Denmark, France, and Poland. While some corporate reports cite exports to 56 countries, other figures suggest around 40 countries, depending on the scope of reporting.

Market Entry Timeline

• South Korea: Home market.
• Denmark: Launched in 2014. Denmark is considered a key market due to its historical association with lactic-acid bacteria.
• Singapore: Launched in 2014.
• France: Launched in 2019.
• Poland: Launched in 2019.

The international strategy combines Korean probiotic technology with local distribution partnerships and market-specific product positioning.

Duolac entered the Singapore market in 2014. The brand’s local business heavily targets healthcare-professional channels, distributing products through clinics, pharmacies, and e-pharmacies. Cell Biotech describes Duolac Singapore as a leading probiotics brand in the local ETC (Ethical/Prescription) market, citing IQVIA data for its position in the category in 2022.

The Singapore operation also emphasizes professional education, engaging with healthcare professionals and participating in academic activities.

Duolac offers a portfolio of products formulated for different age groups and health needs. Availability and formulations vary by country to suit local markets, cultures, and climates. 3

Common categories include:

• Babies and infants
• Children
• Adults
• Family/general daily use
• Digestive health
• Specialized nutritional needs

In Singapore, examples of the portfolio include Duo D-drops, DUOLAC Baby, Yam Yam+, DUOLAC Care, Daily Vitality, and Chewable Family.

Understanding Duolac requires context on its parent company, Cell Biotech Co., Ltd. Unlike brands that act primarily as marketers purchasing generic ingredients, Cell Biotech’s business model encompasses probiotic research, strain development, fermentation, manufacturing, and finished product creation. The company operates specialized facilities and a research center staffed by microbiology specialists.

Beyond consumer probiotics, Cell Biotech engages in pharmaceutical and biotechnology research, microbiome-related studies, and biocosmetic applications.

Duolac and Cell Biotech have received various forms of recognition in South Korea:

• 2002: Listed on KOSDAQ; obtained HACCP/FDA-related safety certifications.
• 2004: Dual-coated lactic acid bacteria patents registered in Korea and Japan.
• 2008: European patent for DUOLAC dual-cation/dual-coating technology.
• 2010: International launch of the DUOLAC brand.
• 2017: Recognition for export performance.

Duolac positions itself as a science-oriented premium probiotic brand. Its marketing pillars include scientific research, proprietary technology, Korean probiotic expertise, manufacturing control, and healthcare-professional engagement.

The underlying philosophy is that probiotics should be developed as scientifically characterized microorganisms rather than treated as generic “good bacteria.” This emphasis on strain identity, stability, and quality control is reflected in the slogan “Probiotics for Life.”

While Duolac markets its products for digestive and microbiome health, probiotic effects are generally strain-specific and product-specific. Evidence supporting one strain or formulation may not automatically apply to all Duolac products or probiotics in general. Statements regarding improved digestion or immune support should not be interpreted as guarantees of specific health outcomes for individuals. Duolac provides general educational information about probiotics and their potential benefits.

1. 듀오락 유산균
2. DUOLAC
3. Duolac Worldwide